CAM
CALA

ClariVest Asset Management’s Calithera Biosciences, Inc CALA Stock Holding History

ClariVest Asset Management’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,275
Closed -$203K – 740
2019
Q3 		$203K Sell
3,275
-30
-0.9% -$2.4K ﹤0.01% 489
2019
Q2 		$258K Sell
3,305
-35
-1% -$3.97K 0.01% 414
2019
Q1 		$450K Buy
3,340
+740
+28% +$77.7K 0.01% 466
2018
Q4 		$209K Sell
2,600
-265
-9% -$26.1K ﹤0.01% 524
2018
Q3 		$300K Sell
2,865
-205
-7% -$19.5K 0.01% 541
2018
Q2 		$307K Sell
3,070
-469
-13% -$53.1K 0.01% 552
2018
Q1 		$445K Buy
3,539
+630
+22% +$98.2K 0.01% 510
2017
Q4 		$487K Buy
2,909
+435
+18% +$111K 0.01% 489
2017
Q3 		$779K Sell
2,474
-164
-6% -$51.7K 0.02% 355
2017
Q2 		$784K Buy
2,638
+1,800
+215% +$481K 0.02% 362
2017
Q1 		$194K Buy
+838
New +$145K ﹤0.01% 491

Other funds holding CALA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ClariVest Asset Management's CALA Position: Q4 2019 in Review

ClariVest Asset Management sold out of Calithera Biosciences, Inc (CALA) in Q4 2019, closing a stake of 3,275 shares — an estimated $203K sold.

ClariVest Asset Management first reported a position in CALA in Q1 2017 and held it in 11 quarters. The position peaked at $784K in Q2 2017. 82 funds tracked by Wall St. Rank hold CALA as of Q4 2019.

  • ClariVest Asset Management reported no remaining Calithera Biosciences, Inc position as of Q4 2019 after selling out during the quarter.
  • ClariVest Asset Management sold 3,275 Calithera Biosciences, Inc shares in Q4 2019, an estimated $203K.
  • ClariVest Asset Management first reported a position in Calithera Biosciences, Inc in Q1 2017 and held it in 11 quarters.
  • ClariVest Asset Management's Calithera Biosciences, Inc position peaked at $784K in Q2 2017.
  • 82 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2019.

Based on ClariVest Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.